Effectiveness of interventions that support penicillin allergy assessment and de-labeling of patients by non-allergy specialists: a systematic review protocol.


Journal

JBI evidence synthesis
ISSN: 2689-8381
Titre abrégé: JBI Evid Synth
Pays: United States
ID NLM: 101764819

Informations de publication

Date de publication:
02 2022
Historique:
pubmed: 27 10 2021
medline: 16 3 2022
entrez: 26 10 2021
Statut: ppublish

Résumé

This review will systematically examine and synthesize the evidence evaluating the effectiveness and safety of interventions that enable non-allergy specialist health care workers to assess allergy risk in patients with reported penicillin allergies and subsequently remove erroneous allergy records. The potential benefits of removing erroneous penicillin allergy labels (de-labeling) are wide-ranging. Penicillin allergy assessment and de-labeling is an antibiotic stewardship priority. Delivery of such assessment and de-labeling by non-allergy specialists has been reported in several studies, but the effectiveness and safety have not been formally synthesized. This is a necessary step in the upscaling of penicillin allergy assessment services. This review will consider quantitative studies using appropriate designs. The studies will include adults and pediatric patients who have undergone penicillin allergy assessment and de-labeling by non-allergy specialists in any health care setting. A range of databases will be searched to identify studies published in English, with no date limit applied. Unpublished studies and gray literature will also be searched. Title and abstract screening, and assessment of selected full texts against the inclusion criteria will be conducted by at least two independent reviewers. Identified studies will be assessed for methodological quality using standardized critical appraisal instruments. Data will be extracted and categorized using the EPOC taxonomy, and the effectiveness and safety of the intervention will be determined. Where possible, data will be pooled to facilitate meta-analysis. Data from heterogeneous studies will be reported narratively. The GRADE approach for grading the certainty of evidence will be followed. PROSPERO CRD42020219044.

Identifiants

pubmed: 34698707
doi: 10.11124/JBIES-21-00075
pii: 02174543-900000000-99556
doi:

Substances chimiques

Penicillins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

624-632

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 JBI.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

West RM, Smith CJ, Pavitt SH, Butler CC, Howard P, Bates C, et al. ‘Warning: allergic to penicillin’: association between penicillin allergy status in 2.3 million NHS general practice electronic health records, antibiotic prescribing and health outcomes. J Antimicrob Chemother 2019;74 (7):2075–2082.
Powell N, Honeyford K, Sandoe J. Impact of penicillin allergy records on antibiotic costs and length of hospital stay: a single-centre observational retrospective cohort. J Hosp Infect 2020;106 (1):35–42.
Trubiano JA, Smibert O, Douglas A, Devchand M, Lambros B, Holmes, et al. The safety and efficacy of an oral penicillin challenge program in cancer patients: a multicenter pilot study. Open Forum Infect Dis 2018;5 (12):306.
Macy E, Contreras R. Health care use and serious infection prevalence associated with penicillin “allergy” in hospitalized patients: a cohort study. J Allergy Clin Immunol 2014;133 (3):790–796.
Blumenthal KG, Shenoy ES, Varughese C, Hurwitz S, Hooper D, Banerji A. Impact of a clinical guideline for prescribing antibiotics to inpatients with reported penicillin or cephalosporin allergies. J Allergy Clin Immunol 2015;135 (2):AB232-AB.
Borch JE, Andersen KE, Bindslev-Jensen C. The prevalence of suspected and challenge-verified penicillin allergy in a university hospital population. Basic Clin Pharmacol Toxicol 2006;98 (4):357–362.
Li M, Krishna MT, Razaq S, Pillay D. A real-time prospective evaluation of clinical pharmaco-economic impact of diagnostic label of ’penicillin allergy’ in a UK teaching hospital. J Clin Path 2014;67 (12):1088–1092.
Blumenthal KG, Shenoy ES, Huang M, Kuhlen JL, Ware WA, Parker RA, et al. The impact of reporting a prior penicillin allergy on the treatment of methicillin-sensitive Staphylococcus aureus bacteremia. PLoS One 2016;11 (7):e0159406.
Charneski L, Deshpande G, Smith SW. Impact of an antimicrobial allergy label in the medical record on clinical outcomes in hospitalized patients. Pharmacotherapy 2011;31 (8):742–747.
Wood CA, Wisniewski RM. Beta-lactams versus glycopeptides in treatment of subcutaneous abscesses infected with Staphylococcus aureus. Antimicrob Agents Chemother 1994;38 (5):1023–1026.
Sigona, Steele JM, Miller CD. Impact of a pharmacist-driven beta-lactam allergy interview on inpatient antimicrobial therapy: a pilot project. J AM Pharm Assoc 2016;56 (6):665–669.
Mattingly TJ 2nd, Fulton A, Lumish RA, Williams AMC, Yoon S, Yuen M, et al. The cost of self-reported penicillin allergy: a systematic review. J Allergy Clin Immunol Pract 2018;6 (5):1649–54.e4.
National Institute for Health and Care Excellence. Drug allergy: diagnosis and management. Clinical guideline [CG183] [internet]. 2014 [cited 2021 Jan 14]. Available from: https://www.nice.org.uk/guidance/cg183.
Krishna MT, Huissoon AP, Li M, Richter A, Pillay DG, Sambanthan D, et al. Enhancing antibiotic stewardship by tackling “spurious” penicillin allergy. Clin Exp Allergy 2017;47 (11):1362–1373.
Chua KYL, Vogrin S, Bury S, Douglas A, Holmes NE, Tan N, et al. The penicillin allergy delabeling program: a multicenter whole-of-hospital health services intervention and comparative effectiveness study. Clin Infect Dis 2021;73 (3):487–496.
du Plessis T, Walls G, Jordan A, Holland DJ. Implementation of a pharmacist-led penicillin allergy de-labelling service in a public hospital. J Antimicrob Chemother 2019;74 (5):1438–1446.
Cooper L, Harbour J, Sneddon J, Seaton RA. Safety and efficacy of de-labelling penicillin allergy in adults using direct oral challenge: a systematic review. JAC Antimicrob Resist 2021;3 (1):dlaa123.
DesBiens M, Scalia P, Ravikumar S, Glick A, Newton H, Erinne O, et al. A closer look at penicillin allergy history: systematic review and meta-analysis of tolerance to drug challenge. Am J Med 2020;133 (4):452.
Englert E, Weeks A. Pharmacist-driven penicillin skin testing service for adults prescribed nonpreferred antibiotics in a community hospital. Am J Health Syst Pharm 2019;76 (24):2060–2069.
Wall GC, Peters L, Leaders CB, Wille JA. Pharmacist-managed service providing penicillin allergy skin tests. Am J Health Syst Pharm 2004;61 (12):1271–1275.
Vyles D, Macy E. Self-reported beta-lactam intolerance: not a class effect, dangerous to patients, and rarely allergy. Expert Rev Anti Infect Ther 2019;17 (6):429–435.
American Academy of Allergy, Asthma & Immunology. Penicillin allergy testing: AAAAI advocacy priority [internet]. 2020 [cited 2021 Apr 13]. Available from: https://www.aaaai.org/about-aaaai/advocacy/penicillin-allergy-testing.
World Health Organization. Antimicrobial stewardship interventions: a practical guide [internet]. 2021 [cited 2021 Jul 2]. Available from: https://apps.who.int/iris/bitstream/handle/10665/340709/9789289054980-eng.pdf.
Krishna MT, Vedanthan PK, Vedanthan R, El Shabrawy RM, Madhan R, Nguyen HL, et al. Is spurious penicillin allergy a major public health concern only in high-income countries? BMJ Glob Health 2021;6 (5):e005437.
Wilcock M, Powell N, Sandoe J. A UK hospital survey to explore healthcare professional views and attitudes to patients incorrectly labelled as penicillin allergic: an antibiotic stewardship patient safety project. Eur J Hosp Pharm 2019;26 (6):329–333.
Trubiano JA, Pai Mangalore R, Baey YW, Le D, Graudins LV, Charles PGP, et al. Old but not forgotten: antibiotic allergies in general medicine (the AGM Study). Med J Aust 2016;204 (7):273.
Sundquist, Bowen BJ, Otabor U, Celestin J, Sorum PC. Proactive penicillin allergy testing in primary care patients labeled as allergic: outcomes and barriers. Postgrad Med 2017;129 (8):915–920.
Lin L, Nagtegaal JE, Buijtels PCAM, Jong E. Antimicrobial stewardship intervention: optimizing antibiotic treatment in hospitalized patients with reported antibiotic allergy. J Hosp Infect 2020;104 (2):137–143.
Maguire M, Hayes BD, Fuh L, Elshaboury R, Gandhi RG, Bor S, et al. Beta-lactam antibiotic test doses in the emergency department. World Allergy Organ J 2020;13 (1):100093.
Savic LC, Khan DA, Kopac P, Clarke RC, Cooke PJ, Dewachter P, et al. Management of a surgical patient with a label of penicillin allergy: narrative review and consensus recommendations. Br J Anaesth 2019;123 (1):e82–e94.
Tufanaru C, Munn Z, Aromataris E, Campbell J, Hopp L. Chapter 3: Systematic reviews of effectiveness. In: Aromataris E, Munn Z, editors. JBI Manual for Evidence Synthesis [internet]. Adelaide: JBI; 2020 [cited 2020 Nov 13]. Available from: https://synthesismanual.jbi.global.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009;339:b2700-b.
Munn Z, Aromataris E, Tufanaru C, Stern C, Porritt K, Farrow J. The development of software and add it to the reference list to support multiple systematic review types: the Joanna Briggs Institute System for the Unified Management, Assessment and Review of Information (JBI SUMARI). Int J Evid Based Healthc 2019;17 (1):36–43.
Cochrane. Effective Practice and Organisation of Care. EPOC taxonomy [internet]. 2015 [cited 2020 Nov 13]. Available from: https://epoc.cochrane.org/epoc-taxonomy.
Tufanaru C, Munn Z, Stephenson M, Aromataris E. Fixed or random effects meta-analysis? Common methodological issues in systematic reviews of effectiveness. Int J Evid Based Healthc 2015;13 (3):196–207.
Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50 (4):1088–1101.
Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315 (7109):629–634.
Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med 2006;25 (20):3443–3457.
Schünemann H, Brożek J, Guyatt G, Oxman A, editors. GRADE handbook for grading quality of evidence and strength of recommendations using the GRADE approach [internet]. 2013. [cited 2020 Nov 12]. Available from: https://gdt.gradepro.org/app/handbook/handbook.html.

Auteurs

Neil Powell (N)

Pharmacy Department, Royal Cornwall Hospital Trust, Truro, Cornwall, UK.
School of Biomedical Sciences, University of Plymouth, Plymouth, Devon, UK.

Declan Kohl (D)

School of Biomedical Sciences, University of Leeds and Leeds Teaching Hospitals NHS Trust, Leeds, West Yorkshire, UK.

Shadia Ahmed (S)

Department of Microbiology, Leeds Teaching Hospitals NHS Trust, Leeds, West Yorkshire, UK.

Bridie Kent (B)

The University of Plymouth Centre for Innovations in Health and Social Care: A JBI Centre of Excellence, Faculty of Health, University of Plymouth, Plymouth, Devon, UK.

Jonathan Sandoe (J)

Leeds Institute of Medical Research, University of Leeds and Leeds Teaching Hospitals NHS Trust, Leeds, West Yorkshire, UK.

Sarah Tonkin-Crine (S)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, Oxfordshire, UK.

Rhys Owens (R)

Department of Critical Care, Royal Cornwall Hospital Trust, Truro, Cornwall, UK.

Jennie Stephens (J)

Department of Medicine, Royal Cornwall Hospital Trust, Truro, Cornwall, UK.

Mathew Upton (M)

School of Biomedical Sciences, University of Plymouth, Plymouth, Devon, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH